BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32433508)

  • 21. Acute lymphoblastic leukemia and chromosome 21.
    Berger R
    Cancer Genet Cytogenet; 1997 Mar; 94(1):8-12. PubMed ID: 9078285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematological disorders and leukemia in children with Down syndrome.
    Bruwier A; Chantrain CF
    Eur J Pediatr; 2012 Sep; 171(9):1301-7. PubMed ID: 22113227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
    Kong XT; Ida K; Ichikawa H; Shimizu K; Ohki M; Maseki N; Kaneko Y; Sako M; Kobayashi Y; Tojou A; Miura I; Kakuda H; Funabiki T; Horibe K; Hamaguchi H; Akiyama Y; Bessho F; Yanagisawa M; Hayashi Y
    Blood; 1997 Aug; 90(3):1192-9. PubMed ID: 9242552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid leukemia in Down syndrome.
    Khan I; Malinge S; Crispino J
    Crit Rev Oncog; 2011; 16(1-2):25-36. PubMed ID: 22150305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
    Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
    Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia.
    Kearney L; Gonzalez De Castro D; Yeung J; Procter J; Horsley SW; Eguchi-Ishimae M; Bateman CM; Anderson K; Chaplin T; Young BD; Harrison CJ; Kempski H; So CW; Ford AM; Greaves M
    Blood; 2009 Jan; 113(3):646-8. PubMed ID: 18927438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
    Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
    Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
    Shim KS; Ferrando-Miguel R; Lubec G
    J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ETS family of genes in leukemia and Down syndrome.
    Papas TS; Watson DK; Sacchi N; Fujiwara S; Seth AK; Fisher RJ; Bhat NK; Mavrothalassitis G; Koizumi S; Jorcyk CL
    Am J Med Genet Suppl; 1990; 7():251-61. PubMed ID: 2149958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down syndrome and leukemia: from basic mechanisms to clinical advances.
    Baruchel A; Bourquin JP; Crispino J; Cuartero S; Hasle H; Hitzler J; Klusmann JH; Izraeli S; Lane AA; Malinge S; Rabin KR; Roberts I; Ryeom S; Tasian SK; Wagenblast E
    Haematologica; 2023 Oct; 108(10):2570-2581. PubMed ID: 37439336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndrome.
    Lanza C; Volpe G; Basso G; Gottardi E; Perfetto F; Cilli V; Spinelli M; Ricotti E; Guerrasio A; Madon E; Saglio G
    Leukemia; 1997 Jun; 11(6):820-1. PubMed ID: 9177434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased levels of a chromosome 21-encoded tumour invasion and metastasis factor (TIAM1) mRNA in bone marrow of Down syndrome children during the acute phase of AML(M7).
    Ives JH; Dagna-Bricarelli F; Basso G; Antonarakis SE; Jee R; Cotter F; Nizetić D
    Genes Chromosomes Cancer; 1998 Sep; 23(1):61-6. PubMed ID: 9713998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
    Xavier AC; Ge Y; Taub JW
    J Mol Diagn; 2009 Sep; 11(5):371-80. PubMed ID: 19710397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trisomy 21 leukemias: finding the hits that matter.
    Rabson AB
    Oncogene; 2010 Nov; 29(46):6099-101. PubMed ID: 20711238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetic and molecular studies of Down syndrome individuals with leukemia.
    Shen JJ; Williams BJ; Zipursky A; Doyle J; Sherman SL; Jacobs PA; Shugar AL; Soukup SW; Hassold TJ
    Am J Hum Genet; 1995 Apr; 56(4):915-25. PubMed ID: 7717402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.
    Taub JW; Matherly LH; Stout ML; Buck SA; Gurney JG; Ravindranath Y
    Blood; 1996 Apr; 87(8):3395-403. PubMed ID: 8605357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Constitutional chromosome abnormalities and leukemia].
    Berger R
    Nouv Rev Fr Hematol; 1970; 10(1):99-107. PubMed ID: 4246340
    [No Abstract]   [Full Text] [Related]  

  • 38. Down syndrome, drug metabolism and chromosome 21.
    Taub JW; Ge Y
    Pediatr Blood Cancer; 2005 Jan; 44(1):33-9. PubMed ID: 15390307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis.
    Attarbaschi A; Mann G; König M; Dworzak MN; Trebo MM; Mühlegger N; Gadner H; Haas OA;
    Leukemia; 2004 Oct; 18(10):1611-6. PubMed ID: 15356655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trisomy 21 in neoplastic cells.
    Mitelman F; Heim S; Mandahl N
    Am J Med Genet Suppl; 1990; 7():262-6. PubMed ID: 2149959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.